Mead Johnson Nutrition (NYSE: MJN) reported earnings on April 26. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Mead Johnson Nutrition met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded and GAAP earnings per share grew.

Gross margins dropped, operating margins dropped, and net margins improved.

Revenue details
Mead Johnson Nutrition reported revenue of $986.6 million. The 10 analysts polled by S&P Capital IQ expected to see a top line of $978.2 million on the same basis. GAAP reported sales were 9.6% higher than the prior-year quarter's $899.8 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Non-GAAP EPS came in at $0.82. The 13 earnings estimates compiled by S&P Capital IQ forecast $0.78 per share on the same basis. GAAP EPS of $0.80 for Q1 were 13% higher than the prior-year quarter's $0.71 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 62.1%, 230 basis points worse than the prior-year quarter. Operating margin was 25.2%, 270 basis points worse than the prior-year quarter. Net margin was 16.6%, 40 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $1.00 billion. On the bottom line, the average EPS estimate is $0.78.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 79 members out of 94 rating the stock outperform, and 15 members rating it underperform. Among 34 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 26 give Mead Johnson Nutrition a green thumbs-up, and eight give it a red thumbs-down.